NFA
FOLD

Nationwide Fund Advisors’s Amicus Therapeutics FOLD Stock Holding History

Nationwide Fund Advisors’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-178,212
Closed -$2.69M – 764
2017
Q3 		$2.69M Buy
178,212
+9,503
+6% +$126K 0.01% 1315
2017
Q2 		$1.7M Buy
168,709
+36,764
+28% +$296K 0.01% 1503
2017
Q1 		$941K Buy
131,945
+13,563
+11% +$85.8K ﹤0.01% 1786
2016
Q4 		$588K Sell
118,382
-2,335
-2% -$16.2K ﹤0.01% 2091
2016
Q3 		$893K Buy
120,717
+8,392
+7% +$56.7K ﹤0.01% 1859
2016
Q2 		$613K Buy
112,325
+8,756
+8% +$61.2K ﹤0.01% 2042
2016
Q1 		$892K Sell
103,569
-2,028
-2% -$14.4K ﹤0.01% 1779
2015
Q4 		$1.02M Buy
105,597
+1,754
+2% +$15.8K ﹤0.01% 1722
2015
Q3 		$1.45M Buy
103,843
+12,253
+13% +$192K 0.01% 1538
2015
Q2 		$1.3M Buy
+91,590
New +$1.1M 0.01% 1707
2014
Q2 		– Sell
-24,464
Closed -$51K – 3339
2014
Q1 		$51K Hold
24,464
– – ﹤0.01% 2854
2013
Q4 		$57K Hold
24,464
– – ﹤0.01% 3055
2013
Q3 		$57K Buy
24,464
+602
+3% +$1.51K ﹤0.01% 3036
2013
Q2 		$56K Buy
+23,862
New +$73.3K ﹤0.01% 2936

Other funds holding FOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Nationwide Fund Advisors's FOLD Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Amicus Therapeutics (FOLD) in Q4 2017, closing a stake of 178,212 shares — an estimated $2.69M sold.

Nationwide Fund Advisors first reported a position in FOLD in Q2 2013 and held it in 14 quarters. The position peaked at $2.69M in Q3 2017. 185 funds tracked by Wall St. Rank hold FOLD as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Amicus Therapeutics position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 178,212 Amicus Therapeutics shares in Q4 2017, an estimated $2.69M.
  • Nationwide Fund Advisors first reported a position in Amicus Therapeutics in Q2 2013 and held it in 14 quarters.
  • Nationwide Fund Advisors's Amicus Therapeutics position peaked at $2.69M in Q3 2017.
  • 185 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.